Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

43
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
43
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

45
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
45
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

28
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
28
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

47
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
47
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

240
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
240
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

191
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
191

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remembering Hans Georg Borst, surgical pioneer, educator, innovator, and medical statesman.

Journal of cardiac surgery·2022
Same author

Should there be an age limit for advanced therapies?

Journal of cardiac surgery·2022
Same author

Adding complexity to complexity: The role of concomitant cardiac surgery in lung transplantation.

Journal of cardiac surgery·2022
Same author

Infections in LVAD patients.

Journal of cardiac surgery·2022
Same author

Left ventricular assist device placement in the setting of congenital VSD.

Journal of cardiac surgery·2022
Same author

Long-term survival: Achilles heel of lung transplantation.

Journal of cardiac surgery·2022

Related Experiment Video

Updated: Sep 22, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Infections in LVAD patients.

Bini Viotti Julia1,2, Natori Yochiro1,2, Loebe Matthias1

  • 1Miami Transplant Institute, University of Miami School of Medicine, Miami, Florida, USA.

Journal of Cardiac Surgery
|May 19, 2022
PubMed
Summary
This summary is machine-generated.

Infections are a major risk for patients with left ventricular assist devices (LVADs). Differentiating early from long-term infections and implementing risk stratification and close follow-up can reduce infection rates.

Keywords:
LVADcardiac functioncirculatory support devicesheart failureinfectionsoutcomes

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

796

Related Experiment Videos

Last Updated: Sep 22, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

796

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Devices

Background:

  • Infections are a significant cause of morbidity and mortality in patients with left ventricular assist devices (LVADs).
  • LVAD infections can be broadly categorized into early-onset (pre-implant factors) and late-onset (drive line issues).

Purpose of the Study:

  • To highlight the importance of distinguishing between early and late infections in LVAD patients.
  • To emphasize the role of pre-implant risk stratification and post-implant monitoring in infection prevention.

Main Methods:

  • Review of existing literature and clinical data on LVAD infections.
  • Analysis of infection patterns based on timing relative to LVAD implantation.
  • Discussion of management strategies for different infection types.

Main Results:

  • Early infections are often linked to the patient's pre-operative condition.
  • Late infections are frequently associated with the LVAD drive line.
  • Effective management requires tailored approaches based on infection timing.

Conclusions:

  • Distinguishing infection types in LVAD patients is crucial for appropriate management.
  • Pre-implant risk assessment and diligent post-implant follow-up are key to reducing LVAD-associated infections.